Consulting Services
For Investors
- Lucid Diligence Briefs
- Venture Capital Trends
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
LucidWargames
QuickAnswers
LucidSearch
BioPharma and Tech News

Contact Us

Search

Samsung Bioepis

Endocrinology

Endocrinology Video Recap—January 13, 2026

This Endocrinology video recap covers regulatory advances, biosimilar market…

Endocrinology

Endocrinology Today—January 5, 2026

Catch up on the latest endocrinology highlights—from major developments and new…

Endocrinology

Endocrinology Video Recap—December 2, 2025

This biweekly endocrinology video recap highlights major shifts in bone and…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Rare Disease News
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Lucid Diligence Brief: PAQ Therapeutics Series B for PT0511 pan-KRAS degrader
AI in Healthcare and Digital Health Today—January 26, 2026
Lucid Diligence Brief: CORXEL $287m Series D1 for oral GLP-1 development
Lucid Diligence Brief: Mendra $82 million Series A to support AI-enabled rare-disease therapeutics
Respiratory Video Recap—January 23, 2026

Tags

AB Science advanced therapies avian influenza B-cell architecture analysis bioinformatics cancer Cardiovascular strategy ckd Clover Biopharmaceuticals CNS-active medications Congenital disorder of glycosylation corporate venture capital drug pricing drug supply chain Elranatamab ENCell enterprise AI ESMO 2021 FDA respiratory approvals gene editing gene therapy approval Glaucoma Global obesity market Global women’s health market Gore Medical HBICE hematology Infectious disease preparedness influenza transmission investment Medical Care Technologies Mitsubishi Tanabe Pharma nanotechnology NFTs in healthcare non viral vectors oncology trials pharma Pimicotinib Plasma value chain Progressive pulmonary fibrosis remote patient monitoring Sema4 Tahoe Therapeutics tissue engineering unconventional trial designs

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Lucid Diligence Brief: PAQ Therapeutics Series B for PT0511 pan-KRAS degrader
AI in Healthcare and Digital Health Today—January 26, 2026
Lucid Diligence Brief: CORXEL $287m Series D1 for oral GLP-1 development
Lucid Diligence Brief: Mendra $82 million Series A to support AI-enabled rare-disease therapeutics
Respiratory Video Recap—January 23, 2026

TAGS

AB Science advanced therapies avian influenza B-cell architecture analysis bioinformatics cancer Cardiovascular strategy ckd Clover Biopharmaceuticals CNS-active medications Congenital disorder of glycosylation corporate venture capital drug pricing drug supply chain Elranatamab ENCell enterprise AI ESMO 2021 FDA respiratory approvals gene editing gene therapy approval Glaucoma Global obesity market Global women’s health market Gore Medical HBICE hematology Infectious disease preparedness influenza transmission investment Medical Care Technologies Mitsubishi Tanabe Pharma nanotechnology NFTs in healthcare non viral vectors oncology trials pharma Pimicotinib Plasma value chain Progressive pulmonary fibrosis remote patient monitoring Sema4 Tahoe Therapeutics tissue engineering unconventional trial designs

Consulting Services
For Investors
- Lucid Diligence Briefs
- Venture Capital Trends
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
LucidWargames
QuickAnswers
LucidSearch
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy